-The Hindustan Times More differently-abled children are going to school, but the gender gap to access education has risen each year since India launched an ambitious programme to get every child with disabilities into a secondary school. A new NCERT study has shown that 11 out of 13 states that shared data on enrolment of differently-abled students have seen more students with disabilities go to school since 2009-10, when the UPA launched...
More »SEARCH RESULT
Total Matching Records found : 2187
Calling big pharma’s bluff -Dwijen Rangnekar
-The Hindu The lesson from the Supreme Court ruling on Gleevec is that pharmaceutical multinational corporations need to focus research on genuine innovations rather than on ways to evergreen their patents The much awaited Supreme Court judgment on Gleevec has been delivered. Novartis has failed in reversing the rejection of its patent. And, predictably - like a scratched record - there have been suggestions that pharma investments in India will dry...
More »When innovation is under threat-Swati Piramal
-The Financial Express A patent law that is transparent, based on principles of good science & encourages innovation is in India's interest In 500 BC, in the Greek city of Sybaris, it was proclaimed that "encouragement was held out to all who should discover any new refinement in luxury, the profits arising from which were secured to the inventor by patent for the space of a year." England followed with the Statute...
More »Gujarat Bill ending role of Governor, CJ to choose ombudsman passed-Darshan Desai
-The Hindu Amid protests and a walkout by Opposition MLAs in the Assembly, the ruling Bharatiya Janata Party on Tuesday pushed through a new Gujarat Lokayukta Aayog Bill, 2013 that ostensibly seeks to end the role of the Governor and the Chief Justice of the High Court in appointing the ombudsman. The Bill proposes a seven-member selection panel headed by the Chief Minister, which will recommend a candidate for the Lokayukta's post...
More »YK Sapru, founder chairperson of Cancer Patients Aid Association (CPAA) interviewed by Sushmi Dey
-The Business Standard Interview with Founder chairman of Cancer Patients Aid Association Though the legal battle over Glivec's patentability may be over for now, Y K Sapru, the man spearheading the fight against Swiss multinational Novartis, isn't resting. Sapru, founder chairman of Cancer Patients Aid Association, or CPAA (which moved the Supreme Court to keep the prices of the cancer drug low), tells Sushmi Dey what the judgment means to cancer patients....
More »
